Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1635 1652 1674
This examiner grants 83% of resolved cases
Dalton Edward Kiefer is an examiner in Tech Center 1600 and Art Unit 1635, with 6 resolved cases. The allowance rate is 83.3 percent, and the median days to allowance is 1120. These figures indicate a high probability of success within a standard timeframe, with five out of six applications reaching a grant in this small sample.
The interview lift is 0.0 percent, which means that interviews have not statistically changed the allowance rate in the cases handled so far. Given the high 83.3 percent baseline allowance rate, applicants may find that written prosecution is sufficient to secure a grant. However, with only 6 cases, this data should be interpreted with caution as the examiner's profile continues to develop.
Strategy for this examiner should focus on the 1120 median days to allowance as a baseline for planning. The 83.3 percent allowance rate is very encouraging, and while the 0.0 percent interview lift suggests no additional benefit, interviews may still be useful for clarifying technical points. Practitioners should focus on high-quality initial filings to take advantage of the high probability of a grant.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18025050 | A RECOMBINANT MICROORGANISM FOR PRODUCING L-GLUTAMIC ACID AND A METHOD FOR PRODUCING L-GLUTAMIC ACID USING THE SAME | Final Rejection | CJ CHEILJEDANG CORPORATION |
| 18708273 | MATERIAL AND METHOD FOR PERFORMING A SEPARATION BASED ON BORON CLUSTERS | Non-Final OA | MERCK PATENT GMBH |
| 18572490 | POLYNUCLEOTIDES ENCODING URIDINE DIPHOSPHATE GLYCOSYLTRANSFERASE 1 FAMILY, POLYPEPTIDE A1 FOR THE TREATMENT OF CRIGLER-NAJJAR SYNDROME | Non-Final OA | ModernaTX, Inc. |
| 18571882 | COMPOSITION WITH IMPROVED MOISTURE MANAGEMENT PERFORMANCE | Non-Final OA | HENKEL AG & CO. KGAA |
| 18791223 | BASE EDITORS AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 18724369 | POLYPEPTIDE AND METHOD FOR PRODUCING AMINO ACID USING SAME | Non-Final OA | CHUGAI SEIYAKU KABUSHIKI KAISHA |
| 18819967 | METHODS AND COMPOSITIONS TO REGULATE MAPT SPLICING FOR MODELING AND TREATMENT OF TAUOPATHIES | Non-Final OA | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy